Merck & Company Inc
Stock Chart, Company Information, and Scan Results
$115.61(as of Mar 13, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Merck & Company Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$115.61
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$285,833.2M
EBIDTA29,105.0M
10-Day Moving Average117.53
P/E Ratio15.76
20-Day Moving Average119.87
Forward P/E Ratio22.52
50-Day Moving Average114.90
Earnings per Share7.28
Profit Margin18.07%
RSI44.70
Shares Outstanding2,472.4M
ATR2.90
52-Week High125.14
Volume7,110,457
52-Week Low71.26
Book Value52,662.0M
P/B Ratio5.46
Upper Keltner126.39
P/S Ratio4.42
Lower Keltner113.35
Debt-to-Equity Ratio126.39
Next Earnings Date04/30/2026
Cash Surplus-13,762.0M
Next Ex-Dividend DateUnknown
This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.
Merck & Company Inc In Our Stock Scanner
As of Mar 16, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.